evolut plasmid vivo strain staphylococcu aureu strain staphylococcu aureu far4 ha isol patient frequent interv 18 month thi strain ha previous shown lose resist sever antibodi lacey et al 1973 dure last 6 month chang occur vivo lincomycin resist appear patient treat clindamycin thi wa due mutat constitut resist lincomycin erythromycin locu adjac determin induc resist erythromycin loci probabl carri extrachromosom element three type variat pf plasmid observ alter product penicillinas macroconstitut microconstitut wa associ ani detect chang plasmid size thi chang gave cell advantag vitro becaus wa associ faster growth rate probabl also vivo becaus microconstitut variant isol increas number flucloxacillin therapi ceas complet loss determin penicillinas product resist cadmium ion pf plasmid wa associ decreas plasmid size 4 x 10 6 dalton thi chang wa also associ increas growth rate vitro loss resist fusid acid pf plasmid wa associ decreas plasmid size 1 x 10 6 dalton